- Conditions
- Large B-cell Lymphoma, TP53
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
Large B-cell Lymphoma
Explore clinical trials studying Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
60 public trials
37 recruiting studies
Large B-cell Lymphoma trial results
NCT07236203
- Conditions
- Disease Attributes, Large B-cell Lymphoma, Pathologic Processes, +2 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05643742
- Conditions
- B-cell Lymphoma, B-cell Malignancy, Chronic Disease, +27 more
- Locations
-
- University of Kansas Westwood, Kansas, United States
- Washington University St Louis, Missouri, United States
- SCRI San Antonio, Texas, United States
- University of Utah Salt Lake City, Utah, United States
NCT05940272
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All protocol activities) New York, United States
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) New York, United States
NCT05794958
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT06743503
- Conditions
- Disease Attributes, Large B-cell Lymphoma, Pathologic Processes, +2 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, China
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
NCT06375733
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute Nanning, China
- Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou, China
Recruiting
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
- Conditions
- B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States
Recruiting
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
NCT06340737
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Stanford University Palo Alto, California, United States